Atropisomerism observed in indometacin derivatives

Organic Letters

Volumn 13, Issue 4, 2011, Pages 760-763

  Takahashi, Hideyo ^a   Wakamatsu, Shintaro ^a   Tabata, Hidetsugu ^a   Oshitari, Tetsuta ^a   Harada, Ayako ^a   Inoue, Keizo ^a   Natsugari, Hideaki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG DERIVATIVE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; METABOLISM; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DRUG DESIGN; INDOMETHACIN; MODELS, MOLECULAR; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79951653586     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol103008d     Document Type: Article

References (28)

1. Hart, F. D.; Boardman, P. L. Br. Med. J. 1963, 2, 965-970
2. Del Soldato, P.; Foschi, D. Gastroenterol. J. 1987, 93, 1149-1150
3. Xie, W. L.; Chipman, J. G.; Robertson, D. L.; Erikson, R. L.; Simmons, D. L. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2692-2696
4. Kujubu, D. A.; Fletcher, B. S.; Varnum, B. C.; Lim, R. W.; Herschman, H. R. J. Biol. Chem. 1991, 266, 12866-12872
5. Morita, I.; Schindler, M.; Regier, M. K.; Otto, J. C.; Hori, T.; Dewitt, D. L.; Smith, W. L. J. Biol. Chem. 1995, 270, 10902-10908
6. Smith, W. L.; Garavito, R. M.; Dewitt, D. L. J. Biol. Chem. 1996, 271, 33157-33160
7. Herschman, H. R. Biochim. Biophys. Acta Lipids Lipid Metab. 1996, 1299, 125-140
8. Gans, K. R.; Galbraith, W.; Roman, R. J.; Haber, S. B.; Kerr, J. S.; Schmidt, W. K.; Smith, C.; Hewes, W. E.; Ackerman, N. R. J. Pharmacol. Exp. Ther. 1990, 254, 180-187
9. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med. Chem. 1997, 40, 1347-1365
10. Depre, M.; Ehrich, E.; Van Hecken, A.; De Lepeleire, I.; Dallob, A.; Wong, P.; Porras, A.; Gertz, B. J.; De Schepper, P. J. Eur. J. Clin. Pharmacol. 2000, 56, 167-174
11. Goto, K.; Ochi, H.; Yasunaga, Y.; Matsuyuki, H.; Imayoshi, T.; Kusuhara, H.; Okumoto, T. Prostaglandins Other Lipid Mediators 1998, 56, 245-254
12. Loll, P. J.; Picot, D.; Ekabo, O.; Garavito, R. M. Biochemistry 1996, 35, 7330-7340
13. Kurumbail, R. G.; Stevens, A. M.; Gierse, J. K.; McDonald, J. J.; Stegeman, R. A.; Pak, J. Y.; Gildehaus, D.; Miyashiro, J. M.; Penning, T. D.; Seibert, K.; Isakson, P. C.; Stallings, W. C. Nature 1996, 384, 644-648
14. Kakuta, H.; Zheng, X.; Oda, H.; Harada, S.; Sugimoto, Y.; Sasaki, K.; Tai, A. J. Med. Chem. 2008, 51, 2400-2411
15. Kasaya, Y.; Hoshi, K.; Terada, Y.; Nishida, A.; Shuto, S.; Arisawa, M. Eur. J. Org. Chem. 2009, 4606-4613
16. Loll, P. J.; Garavito, R. M.; Carrell, C. J.; Carrell, H. L. Acta Crystallogr., Sect. C 1996, C52, 455-457
17. Xiaoming, C.; Morris, K. R.; Griesser, U. J.; Byrn, S. R.; Stowell, J. G. J. Am. Chem. Soc. 2002, 124, 15012-15019
18. Clayden, J. Tetrahedron 2004, 60, 4335. Tetrahedron Symposia-in-Print on Atropisomerism
19. Clayden, J. Angew. Chem., Int. Ed. 1997, 36, 949-951
20. Ikeura, Y.; Doi, T.; Fujishima, A.; Natsugari, H. Chem. Commun. 1998, 2141-2142
21. Ikeura, Y.; Ishichi, Y.; Tanaka, T.; Fujishima, A.; Murabayashi, M.; Kawada, M.; Ishimaru, T.; Kamo, I.; Doi, T.; Natsugari, H. J. Med. Chem. 1998, 41, 4232-4239
22. Natsugari, H.; Ikeura, Y.; Kamo, I.; Ishimaru, T.; Ishichi, Y.; Fujishima, A.; Tanaka, T.; Kasahara, F.; Kawada, M.; Doi, T. J. Med. Chem. 1999, 42, 3982-3993
23. Tabata, H.; Akiba, K.; Shoukou, L.; Takahashi, H.; Natsugari, H. Org. Lett. 2008, 10, 4871-4874
24. Tabata, H.; Suzuki, H.; Akiba, Kumi; Takahashi, H.; Natsugari, H. J. Org. Chem. 2010, 75, 5984-5993
25. Clayden, J.; Moran, W. J.; Edwards, P. J.; LaPlante, S. R. Angew. Chem., Int. Ed. 2009, 48, 6398-6401
26. These " trans-like/ cis-like" terms have the implication that the carbonyl group takes a type of perpendicular position with respect to the plane of the phenyl group of the benzoyl moiety.
27. In order to examine the equilibrium between the cis-/ trans-conformers, VT-NMR has been measured (see: Supporting Information).
28. Petit, M.; Lapierre, A. J. B.; Curran, D. P. J. Am. Chem. Soc. 2005, 127, 14994-14995